High throughput genotyping and DNA sequencing for studying the genetic contributions to human health and disease: whole genome sequencing (30X) - blood DNA source for nichd (morrow)
Ended Awarded Last action
- Contract number
- 75N92021F00009
- Awardee
-
The Johns Hopkins University UEI FTMTDMBR29C7
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $506,000
Award facts
- Contract value 100% obligated
- $506,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Baltimore, MD 21218, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Original award | $506,000 |
About this award
The Johns Hopkins University was awarded a $506,000 firm fixed-price delivery order by the National Heart, Lung, and Blood Institute (NHLBI) on September 17, 2021, for high-throughput genotyping and DNA sequencing services. The contract, which was completed on September 16, 2023, involved whole genome sequencing at 30x coverage depth using blood DNA samples to support research conducted by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The work was performed at Johns Hopkins' Baltimore, Maryland facility, with no set-aside designation applied to the award, indicating open competition based on technical qualifications.
This delivery order falls within Johns Hopkins University's broader federal research portfolio, which encompasses extensive biomedical and health-related research services across multiple National Institutes of Health agencies. The contract supports critical genetic research aimed at understanding the hereditary contributions to human health and disease outcomes, aligning with the NHLBI's mission to advance cardiovascular, pulmonary, and blood research. As a leading research institution with significant federal contracting experience, Johns Hopkins routinely provides sophisticated molecular and genomic services that directly support federal agencies' research objectives and evidence generation activities.
Quick answers
Who was awarded contract 75N92021F00009?
75N92021F00009 was awarded to The Johns Hopkins University by National Heart Lung and Blood Institute (National Institutes of Health) on September 17, 2021.
How much is contract 75N92021F00009 worth?
The government has obligated $506,000 on 75N92021F00009.
Is contract 75N92021F00009 an order under another contract?
Yes. 75N92021F00009 is a delivery order under HHSN268201700006I, an indefinite delivery contract.
Was contract 75N92021F00009 competed?
The extent of competition for 75N92021F00009 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award